Comparison of Local Anesthetic Infusion Pump Versus DepoFoam Bupivacaine for Pain Management
Status:
Unknown status
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to identify the best pain management for patients undergoing
abdominoplasty after massive weight loss or transverse rectus abdominis myocutaneous (TRAM)
flap for breast reconstruction. The investigator is conducting this study to compare the
effectiveness of a continuous infusion pain pump versus a locally injectable long-acting
anesthesia (DepoFoam bupivacaine) versus standard injectable anesthesia (bupivacaine) for
post surgical pain control. These drugs and devices are approved by the FDA (Food and Drug
Administration) for the purpose of pain control after surgery, and have been used for this
purpose before.